November 2025 Newsletter – Our most versatile solution 🤝 Your latest product formulation
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
Lycopene and bone: an in vitro investigation and a pilot prospective clinical study
Sep 18, 2025
There are several effective therapies for osteoporosis but these agents might cause serious adverse events. Lycopene intake could prevent bone loss, however studies on its effects on bone are scarce. Our aim was to investigate the effects of lycopene on osteoblast cells as well as bone mineral density and bone turnover markers in postmenopausal women.
File Type:
www
Categories:
By Others, Lycopene
Continue reading
Lycored Debuts New VAS Technology at SupplySide Global
BRANCHBURG, N.J., Oct. 29, 2025 /PRNewswire/ — Lycored, the global leader in naturally derived carotenoids for the food, beverage and dietary supplement market, is expanding its ingredient capabilities with the...
Dafna Cohen-Asher Named CEO of ADAMA’s Lycored
BEIJING and TEL AVIV, Israel, Oct. 22, 2025 /PRNewswire/ — ADAMA (SZSE: 000553), a global leader in crop protection, has announced the appointment of Dafna Cohen-Asher as Chief Executive Officer of Lycored,...
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.